title: Coexistence case of bullous pemphigoid and pemphigus foliaceus.
authors.affiliation: Dept. of Dermatology, Hokkaido University Graduate School of Medicine N15 W7, Sapporo 060-8638, Japan.
authors.forename: Masumi
authors.initials: M
authors.lastname: Tsujiwaki
authors.forename: Riichiro
authors.initials: R
authors.lastname: Abe
authors.forename: Yukiko
authors.initials: Y
authors.lastname: Nomura
authors.forename: Machiko
authors.initials: M
authors.lastname: Nishimura
authors.forename: Daichi
authors.initials: D
authors.lastname: Hoshina
authors.forename: Satoru
authors.initials: S
authors.lastname: Shinkuma
authors.forename: Ken
authors.initials: K
authors.lastname: Natsuga
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Ujiie
authors.forename: Ken
authors.initials: K
authors.lastname: Arita
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shimizu
mesh_terms: D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D008297:Male; D010391:Pemphigoid, Bullous / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D010392:Pemphigus / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D016756:Immunoglobulins, Intravenous; D007155:Immunologic Factors; D011239:Prednisolone